WallStreetZenWallStreetZen

NASDAQ: ACLX
Arcellx Inc Stock Ownership - Who owns Arcellx?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcellx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rami ElghandourPresident CEO and Chairman of the Board2026-02-2789,916$113.92
$10.24MSell
Michelle GilsonCHIEF FINANCIAL OFFICER2026-02-2511,219$113.82
$1.28MSell
Michelle GilsonCHIEF FINANCIAL OFFICER2026-02-192,879$67.73
$194.99kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2026-02-19100$69.38
$6.94kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2026-02-195,405$68.57
$370.64kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2026-02-177,141$69.21
$494.23kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2026-02-174,150$70.01
$290.55kSell
David Charles LubnerDirector2026-01-206,000$6.28
$37.68kBuy
David Charles LubnerDirector2026-01-206,000$75.00
$450.00kSell
Christopher HeeryCHIEF MEDICAL OFFICER2026-01-145,882$68.51
$403.00kSell

1 of 4

ACLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACLX insiders and whales buy or sell their stock.

ACLX Shareholders

What type of owners hold Arcellx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc18.06%10,560,425$1.20BInstitution
Gilead Sciences Inc11.49%6,720,803$766.51MInstitution
Gilead Sciences Inc11.49%6,720,803$766.51MInsider
Sr One Capital Management LLC11.15%6,520,370$743.65MInsider
Jill Carroll10.84%6,340,738$723.16MInsider
Paradigm Biocapital Advisors LP9.79%5,724,016$652.82MInstitution
Scott D. Sandell8.12%4,748,116$541.52MInsider
Peter W. Sonsini8.12%4,746,083$541.29MInsider
Mohamad Makhzoumi8.11%4,745,545$541.23MInsider
Nea Partners 15 LP8.11%4,745,262$541.20MInsider

1 of 3

ACLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACLX52.82%47.18%Net SellingNet Selling
KYMR77.07%22.93%Net BuyingNet Buying
RYTM88.72%11.28%Net SellingNet Selling
COGT92.60%7.40%Net SellingNet Selling
CYTK90.05%9.95%Net SellingNet Buying
View Top Biotech Stocks

Arcellx Stock Ownership FAQ

Who owns Arcellx?

Arcellx (NASDAQ: ACLX) is owned by 113.92% institutional shareholders, 101.74% Arcellx insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcellx shareholder, owning 6.72M shares representing 11.49% of the company. Gilead Sciences Inc's Arcellx shares are currently valued at $766.51M.

If you're new to stock investing, here's how to buy Arcellx stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.